Search Results

You are looking at 191 - 200 of 1,245 items for :

  • Refine by Access: All x
Clear All
Full access

Fikri İçli, Hakan Akbulut, Shouki Bazarbashi, Mehmet Ayhan Kuzu, Mohandas K. Mallath, Kakil Ibrahim Rasul, Scott Strong, Aamir Ali Syed, Faruk Zorlu, and Paul F. Engstrom

in accordance with the NCCN Guidelines, except those related to questions number 1 and 10. According to the results, 69% did not perform routine chest CT before surgery for all patients with colon cancer. With regard to first-line chemotherapy for

Full access

Jaffer A. Ajani

Bray F Ferlay J Pisani P . Global cancer statistics, 2002 . CA Cancer J Clin 2005 ; 55 : 74 – 108 . 4. Macdonald JS Smalley SR Benedetti J . Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or

Full access

Nisar Ahmad, Denise M. Adams, Jiang Wang, Rajan Prakash, and Nagla Abdel Karim

patient was referred for a liver transplant but was deemed inappropriate for transplant secondary to peritoneal studding, and frozen section analysis showed metastatic disease at the time of surgery. Case Presentation A 24-year-old woman with no

Full access

William J. Gradishar, Benjamin O. Anderson, Sarah L. Blair, Harold J. Burstein, Amy Cyr, Anthony D. Elias, William B. Farrar, Andres Forero, Sharon Hermes Giordano, Lori J. Goldstein, Daniel F. Hayes, Clifford A. Hudis, Steven J. Isakoff, Britt-Marie E. Ljung, P. Kelly Marcom, Ingrid A. Mayer, Beryl McCormick, Robert S. Miller, Mark Pegram, Lori J. Pierce, Elizabeth C. Reed, Kilian E. Salerno, Lee S. Schwartzberg, Mary Lou Smith, Hatem Soliman, George Somlo, John H. Ward, Antonio C. Wolff, Richard Zellars, Dorothy A. Shead, and Rashmi Kumar

Approach Conceptually, the treatment of breast cancer includes the treatment of local disease with surgery, radiation therapy, or both, and the treatment of systemic disease with cytotoxic chemotherapy, endocrine therapy, biologic therapy, or combinations

Full access

Al B. Benson III, Alan P. Venook, Mahmoud M. Al-Hawary, Mustafa A. Arain, Yi-Jen Chen, Kristen K. Ciombor, Stacey A. Cohen, Harry S. Cooper, Dustin A. Deming, Ignacio Garrido-Laguna, Jean L. Grem, Sarah E. Hoffe, Joleen Hubbard, Steven Hunt, Ahmed Kamel, Natalie Kirilcuk, Smitha Krishnamurthi, Wells A. Messersmith, Jeffrey Meyerhardt, Eric D. Miller, Mary F. Mulcahy, Steven Nurkin, Michael J. Overman, Aparna Parikh, Hitendra Patel, Katrina S. Pedersen, Leonard B. Saltz, Charles Schneider, David Shibata, John M. Skibber, Constantinos T. Sofocleous, Elena M. Stoffel, Eden Stotsky-Himelfarb, Christopher G. Willett, Alyse Johnson-Chilla, Kristina M. Gregory, and Lisa A. Gurski

associated with a lower ratio of positive-to-negative lymph nodes as well as with a higher number of regional lymph nodes assessed during surgery. 38 , 58 – 60 Two of these analyses, which considered duodenal and jejunoileal adenocarcinomas separately

Full access

Yan Si, Jingsheng Cai, Hao Zhang, Haisheng Fang, and Meiping Shen

patients who receive initial thyroid surgery in our center, describe the structural features of TTL, and investigate the positional relationship of TTL and IPTG. Results: TTL is a kind of adipose connective tissue that is wide at the bottom and narrow at

Full access

Nawin Kuntaraksa

sampled and assigned to Group 1 (lymphatic ligation; n=34) and Group 2 (conventional surgery; n=35). Results: 18 patients had developed seroma (26.09%) with 8 (23.53%) patients who were in the lymphatic ligation group and 10 (28.57%) patients who were in

Full access

Namrata Vijayvergia, Prashant C. Shah, and Crystal S. Denlinger

undergone invasive treatment, including surgery, radiation therapy, and/or chemotherapy, resulting in a higher comorbidity burden compared with survivors of other cancers. 5 These treatments and their effects can impact QOL, both temporarily after treatment

Full access

Charlotte E.L. Klaver, Lieke Gietelink, Willem A. Bemelman, Michel W.J.M. Wouters, Theo Wiggers, Rob A.E.M. Tollenaar, Pieter J. Tanis, and on behalf of the Dutch Surgical Colorectal Audit Group

Dutch Surgical Colorectal Audit (DSCA) has been evaluating and reporting on the quality of care of primary CRC surgery since 2009. 7 , 8 The goal of this study was to evaluate current clinical practice regarding and short-term outcomes of the treatment

Full access

Beryl McCormick

, delivered with a specially designed mobile linear accelerator using electrons, or the ELIOT technique. The dose is a single dose of 21 Gy in the experimental arm delivered at the time of breast surgery. The standard treatment arm includes postoperative WBRT